132 related articles for article (PubMed ID: 30815677)
21. Aberrant promoter methylation may be responsible for the control of CD146 (MCAM) gene expression during breast cancer progression.
Dudzik P; Trojan SE; Ostrowska B; Lasota M; Dulińska-Litewka J; Laidler P; Kocemba-Pilarczyk KA
Acta Biochim Pol; 2019 Dec; 66(4):619-625. PubMed ID: 31826047
[TBL] [Abstract][Full Text] [Related]
22. Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice.
Schlagbauer-Wadl H; Jansen B; Müller M; Polterauer P; Wolff K; Eichler HG; Pehamberger H; Konak E; Johnson JP
Int J Cancer; 1999 Jun; 81(6):951-5. PubMed ID: 10362144
[TBL] [Abstract][Full Text] [Related]
23. Pro- and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition.
Mannion AJ; Odell AF; Baker SM; Matthews LC; Jones PF; Cook GP
Front Cell Dev Biol; 2023; 11():1129015. PubMed ID: 37138793
[TBL] [Abstract][Full Text] [Related]
24. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.
Pickl WF; Majdic O; Fischer GF; Petzelbauer P; Faé I; Waclavicek M; Stöckl J; Scheinecker C; Vidicki T; Aschauer H; Johnson JP; Knapp W
J Immunol; 1997 Mar; 158(5):2107-15. PubMed ID: 9036955
[TBL] [Abstract][Full Text] [Related]
25. MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway.
Tripathi SC; Fahrmann JF; Celiktas M; Aguilar M; Marini KD; Jolly MK; Katayama H; Wang H; Murage EN; Dennison JB; Watkins DN; Levine H; Ostrin EJ; Taguchi A; Hanash SM
Cancer Res; 2017 Aug; 77(16):4414-4425. PubMed ID: 28646020
[TBL] [Abstract][Full Text] [Related]
26. Galectin-3 Is a Natural Binding Ligand of MCAM (CD146, MUC18) in Melanoma Cells and Their Interaction Promotes Melanoma Progression.
Pang Y; Maxwell E; Sindrewicz-Goral P; Shapanis A; Li S; Morgan M; Yu LG
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291660
[TBL] [Abstract][Full Text] [Related]
27. Laminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146).
Ishikawa T; Wondimu Z; Oikawa Y; Gentilcore G; Kiessling R; Egyhazi Brage S; Hansson J; Patarroyo M
Matrix Biol; 2014 Sep; 38():69-83. PubMed ID: 24951930
[TBL] [Abstract][Full Text] [Related]
28. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
Jean D; Gershenwald JE; Huang S; Luca M; Hudson MJ; Tainsky MA; Bar-Eli M
J Biol Chem; 1998 Jun; 273(26):16501-8. PubMed ID: 9632718
[TBL] [Abstract][Full Text] [Related]
29. Melanoma cell adhesion molecule (MCAM/CD146) is expressed on human luteinizing granulosa cells: enhancement of its expression by hCG, interleukin-1 and tumour necrosis factor-alpha.
Yoshioka S; Fujiwara H; Higuchi T; Yamada S; Maeda M; Fujii S
Mol Hum Reprod; 2003 Jun; 9(6):311-9. PubMed ID: 12771231
[TBL] [Abstract][Full Text] [Related]
30. Expression of the cell adhesion molecule CD146/MCAM in non-small cell lung cancer.
Kristiansen G; Yu Y; Schlüns K; Sers C; Dietel M; Petersen I
Anal Cell Pathol; 2003; 25(2):77-81. PubMed ID: 12632016
[TBL] [Abstract][Full Text] [Related]
31. Melanoma progression-associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand.
Johnson JP; Bar-Eli M; Jansen B; Markhof E
Int J Cancer; 1997 Nov; 73(5):769-74. PubMed ID: 9398060
[TBL] [Abstract][Full Text] [Related]
32. CD146/MCAM links doxorubicin-induced epigenetic dysregulation to the impaired fatty acid transportation in H9c2 cardiomyoblasts.
Hasan AU; Obara M; Sato S; Kondo Y; Taira E
Biochem Biophys Res Commun; 2024 Jan; 693():149370. PubMed ID: 38100998
[TBL] [Abstract][Full Text] [Related]
33. The role of N-cadherin, MCAM and beta3 integrin in melanoma progression, proliferation, migration and invasion.
Watson-Hurst K; Becker D
Cancer Biol Ther; 2006 Oct; 5(10):1375-82. PubMed ID: 16969099
[TBL] [Abstract][Full Text] [Related]
34. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
[TBL] [Abstract][Full Text] [Related]
35. Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
Onstenk W; Kraan J; Mostert B; Timmermans MM; Charehbili A; Smit VT; Kroep JR; Nortier JW; van de Ven S; Heijns JB; Kessels LW; van Laarhoven HW; Bos MM; van de Velde CJ; Gratama JW; Sieuwerts AM; Martens JW; Foekens JA; Sleijfer S
Mol Cancer Ther; 2015 Mar; 14(3):821-7. PubMed ID: 25552367
[TBL] [Abstract][Full Text] [Related]
36. CD146, from a melanoma cell adhesion molecule to a signaling receptor.
Wang Z; Xu Q; Zhang N; Du X; Xu G; Yan X
Signal Transduct Target Ther; 2020 Aug; 5(1):148. PubMed ID: 32782280
[TBL] [Abstract][Full Text] [Related]
37. MCAM knockdown impairs PPARγ expression and 3T3-L1 fibroblasts differentiation to adipocytes.
Gabrielli M; Romero DG; Martini CN; Raiger Iustman LJ; Vila MDC
Mol Cell Biochem; 2018 Nov; 448(1-2):299-309. PubMed ID: 29468504
[TBL] [Abstract][Full Text] [Related]
38. Stem-Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients.
Rapanotti MC; Campione E; Suarez Viguria TM; Spallone G; Costanza G; Rossi P; Orlandi A; Valenti P; Bernardini S; Bianchi L
Front Mol Biosci; 2020; 7():92. PubMed ID: 32548126
[TBL] [Abstract][Full Text] [Related]
39. Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.
Chen Y; Sumardika IW; Tomonobu N; Winarsa Ruma IM; Kinoshita R; Kondo E; Inoue Y; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Liu M; Futami J; Sasai K; Katayama H; Kubo M; Putranto EW; Hibino T; Sun B; Nishibori M; Toyooka S; Sakaguchi M
Cancer Lett; 2019 Jun; 452():178-190. PubMed ID: 30904617
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies to human laminin α4 chain globular domain inhibit tumor cell adhesion and migration on laminins 411 and 421, and binding of α6β1 integrin and MCAM to α4-laminins.
Ishikawa T; Wondimu Z; Oikawa Y; Ingerpuu S; Virtanen I; Patarroyo M
Matrix Biol; 2014 Jun; 36():5-14. PubMed ID: 24681327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
